-
1 Comment
Neurotech International Limited is currently in a long term uptrend where the price is trading 10.8% above its 200 day moving average.
From a valuation standpoint, the stock is 45.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 373.6.
Neurotech International Limited's total revenue sank by 22.7% to $31K since the same quarter in the previous year.
Its net income has dropped by 374.6% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 103.6% to $-445K since the same quarter in the previous year.
Based on the above factors, Neurotech International Limited gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| CurrencyCode | AUD |
| ISIN | AU000000NTI9 |
| Exchange | AU |
| Market Cap | 26M |
|---|---|
| PE Ratio | None |
| Target Price | 0.6 |
| Beta | 0.41 |
| Dividend Yield | None |
Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxation in autistic children exhibiting elevated delta band brain activity. It also engages in executing medical research projects; and developing technological devices. The company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its proprietary NTI/Dolce cannabis strains. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NTI.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
